Delayed
OTC Markets
12:59:15 2024-05-21 pm EDT
|
5-day change
|
1st Jan Change
|
0.00065
USD
|
-18.75%
|
|
+16.67%
|
-12.50%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
0.2992
|
1.136
|
1.665
|
6.163
|
22.4
|
2.145
|
Enterprise Value (EV)
1 |
1.423
|
2.311
|
3.407
|
7.975
|
24.24
|
4.776
|
P/E ratio
|
-1.07
x
|
-13
x
|
-4.6
x
|
-1.75
x
|
-1.25
x
|
-0.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.31
x
|
1.12
x
|
1.43
x
|
4.42
x
|
21.4
x
|
2.88
x
|
EV / Revenue
|
1.46
x
|
2.28
x
|
2.93
x
|
5.72
x
|
23.2
x
|
6.41
x
|
EV / EBITDA
|
-6.11
x
|
-73.9
x
|
-6.96
x
|
-2.52
x
|
-1.86
x
|
-2.09
x
|
EV / FCF
|
204
x
|
55.2
x
|
44.5
x
|
-613
x
|
21.5
x
|
-11.3
x
|
FCF Yield
|
0.49%
|
1.81%
|
2.25%
|
-0.16%
|
4.65%
|
-8.83%
|
Price to Book
|
-0.2
x
|
-0.71
x
|
-1.23
x
|
-2.09
x
|
-10.7
x
|
-0.61
x
|
Nbr of stocks (in thousands)
|
49,874
|
94,699
|
294,699
|
560,299
|
1,493,143
|
1,533,255
|
Reference price
2 |
0.006000
|
0.0120
|
0.005650
|
0.0110
|
0.0150
|
0.001399
|
Announcement Date
|
8/24/18
|
10/23/19
|
10/14/20
|
11/19/21
|
10/13/22
|
10/20/23
|
Fiscal Period: Junio |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.976
|
1.015
|
1.163
|
1.394
|
1.046
|
0.7451
|
EBITDA
1 |
-0.233
|
-0.0313
|
-0.4895
|
-3.17
|
-13.04
|
-2.282
|
EBIT
1 |
-0.2356
|
-0.042
|
-0.4956
|
-3.177
|
-13.04
|
-2.294
|
Operating Margin
|
-24.14%
|
-4.14%
|
-42.61%
|
-227.85%
|
-1,247.22%
|
-307.9%
|
Earnings before Tax (EBT)
1 |
-0.2792
|
-0.0872
|
-0.4538
|
-3.313
|
-13.05
|
-2.388
|
Net income
1 |
-0.2792
|
-0.0872
|
-0.4538
|
-3.313
|
-13.05
|
-2.388
|
Net margin
|
-28.61%
|
-8.59%
|
-39.01%
|
-237.64%
|
-1,247.66%
|
-320.56%
|
EPS
2 |
-0.005598
|
-0.000920
|
-0.001227
|
-0.006291
|
-0.0120
|
-0.001555
|
Free Cash Flow
1 |
0.006974
|
0.0418
|
0.0766
|
-0.013
|
1.127
|
-0.422
|
FCF margin
|
0.71%
|
4.12%
|
6.58%
|
-0.93%
|
107.8%
|
-56.63%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/24/18
|
10/23/19
|
10/14/20
|
11/19/21
|
10/13/22
|
10/20/23
|
Fiscal Period: June |
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
0.2263
|
0.2165
|
0.198
|
0.1938
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.9586
|
-0.76
|
-0.5194
|
-0.4796
|
Operating Margin
|
-423.61%
|
-351.12%
|
-262.29%
|
-247.56%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/13/22
|
11/14/22
|
2/21/23
|
5/22/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1.12
|
1.17
|
1.74
|
1.81
|
1.85
|
2.63
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-4.822
x
|
-37.55
x
|
-3.558
x
|
-0.5716
x
|
-0.1417
x
|
-1.153
x
|
Free Cash Flow
1 |
0.01
|
0.04
|
0.08
|
-0.01
|
1.13
|
-0.42
|
ROE (net income / shareholders' equity)
|
20.2%
|
5.58%
|
20.2%
|
98.8%
|
480%
|
84.3%
|
ROA (Net income/ Total Assets)
|
-45.6%
|
-10%
|
-81.2%
|
-377%
|
-1,308%
|
-510%
|
Assets
1 |
0.6123
|
0.8675
|
0.5587
|
0.8794
|
0.9978
|
0.4683
|
Book Value Per Share
2 |
-0.0300
|
-0.0200
|
-0
|
-0.0100
|
-0
|
-0
|
Cash Flow per Share
2 |
0
|
0
|
-
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
0.05
|
0.01
|
Capex / Sales
|
-
|
-
|
-
|
-
|
4.78%
|
1.27%
|
Announcement Date
|
8/24/18
|
10/23/19
|
10/14/20
|
11/19/21
|
10/13/22
|
10/20/23
|
|
1st Jan change
|
Capi.
|
---|
| -12.50% | 1.46M | | +73.28% | 12.38B | | -20.38% | 7.81B | | +5.84% | 6.72B | | +12.78% | 5.39B | | +38.73% | 5.03B | | -16.79% | 4.72B | | -22.01% | 4.06B | | -29.88% | 2.68B | | +52.71% | 2.59B |
Medical Equipment
|